Umedeor: Funding, Investors & Team (Sep 2026)
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams. umed.io
Umedeor has raised $17.3M across 3 funding rounds on record, the most recent a Series A of $12.5M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Umedeor Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Umedeor Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Umedeor raised $4.8M in an undisclosed round announced in Dec 2020.
2 years later, an undisclosed round was announced in Dec 2022 with no disclosed amount.
7 months later, a Series A of $12.5M was announced in Jul 2023.
Umedeor Founders and Leadership Team
Contact details for the Umedeor team: 1 of 1 has an email address on file.
Start 14-day free trial →Umedeor Funding Compared to Other Biotechnology Startups
Umedeor's latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Umedeor in Biotechnology and London
Companies Similar to Umedeor
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Umedeor Funding FAQs
What does Umedeor do?
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams. umed.io
How much funding has Umedeor raised?
Umedeor has raised $17.3M across 3 rounds on record. The most recent is a Series A of $12.5M announced in Jul 2023.
When did Umedeor last raise funding?
Umedeor's most recent funding round on record is a Series A of $12.5M, announced in Jul 2023.
Who is the CEO of Umedeor?
Matt Wilson is listed as CEO at Umedeor.
Where is Umedeor headquartered?
Umedeor is based in London, England, United Kingdom.
How many employees does Umedeor have?
Umedeor is in the 11-50 employee band.
How does Umedeor's funding compare to other Biotechnology startups?
Umedeor's latest round of $12.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Umedeor Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Umedeor is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.